Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lachmann

Showing results (201-210 of 426) with videos related to

Pageof 43
Sort By:
Complement (Basel, Switzerland)|January 1, 1987
Specificity of membrane complement receptor type three (CR3) for beta-glucansG D Ross, J A Cain, B L Myones, et al.
The Journal of General Virology|September 1, 1990
The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host's previous exposure to similar epitopes on unrelated antigensD Davis, B Chaudhri, D M Stephens, et al.
Clinical and Experimental Immunology|March 1, 1990
Peptide inhibitors of C3 breakdownP Peake, M Szelke, D M Jones, et al.
Scandinavian Journal of Haematology|August 1, 1975
Lymphosarcoma, cold urticaria, IgG1 monoclonal cryoglobulin and complement abnormalitiesG Hauptmann, J M Lang, M L North, et al.
The Journal of Biological Chemistry|March 10, 1985
A synthetic nonapeptide corresponding to the NH2-terminal sequence of C3d-K causes leukocytosis in rabbitsP D Hoeprich, C A Dahinden, P J Lachmann, et al.
Practical Neurology|March 12, 2016
Trapped without a diagnosis: Tumour necrosis factor receptor-associated periodic syndrome (TRAPS)Ali Kirresh, Alex Everitt, Onn Min Kon, et al.
QJM : Monthly Journal of the Association of Physicians|April 9, 2002
Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable diseaseH J Lachmann, J A Gilbertson, J D Gillmore, et al.
QJM : Monthly Journal of the Association of Physicians|October 6, 2001
Prevalence and significance of the familial Mediterranean fever gene mutation encoding pyrin Q148D R Booth, H J Lachmann, J D Gillmore, et al.
Complement (Basel, Switzerland)|January 1, 1988
Structure of C3f, a small peptide specifically released during inactivation of the third component of complementR A Harrison, T C Farries, F D Northrop, et al.
Rheumatology Advances in Practice|September 1, 2021
COVID-19 and autoinflammatory diseases: prevalence and outcomes of infection and early experience of vaccination in patients on biologicsClaire J Peet, Charalampia Papadopoulou, Bella Ruth M Sombrito, et al.
Pageof 43

Showing results (201-210 of 426) with videos related to

Sort By:
Pageof 43
Complement (Basel, Switzerland)|January 1, 1987
Specificity of membrane complement receptor type three (CR3) for beta-glucansG D Ross, J A Cain, B L Myones, et al.
The Journal of General Virology|September 1, 1990
The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host's previous exposure to similar epitopes on unrelated antigensD Davis, B Chaudhri, D M Stephens, et al.
Clinical and Experimental Immunology|March 1, 1990
Peptide inhibitors of C3 breakdownP Peake, M Szelke, D M Jones, et al.
Scandinavian Journal of Haematology|August 1, 1975
Lymphosarcoma, cold urticaria, IgG1 monoclonal cryoglobulin and complement abnormalitiesG Hauptmann, J M Lang, M L North, et al.
The Journal of Biological Chemistry|March 10, 1985
A synthetic nonapeptide corresponding to the NH2-terminal sequence of C3d-K causes leukocytosis in rabbitsP D Hoeprich, C A Dahinden, P J Lachmann, et al.
Practical Neurology|March 12, 2016
Trapped without a diagnosis: Tumour necrosis factor receptor-associated periodic syndrome (TRAPS)Ali Kirresh, Alex Everitt, Onn Min Kon, et al.
QJM : Monthly Journal of the Association of Physicians|April 9, 2002
Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable diseaseH J Lachmann, J A Gilbertson, J D Gillmore, et al.
QJM : Monthly Journal of the Association of Physicians|October 6, 2001
Prevalence and significance of the familial Mediterranean fever gene mutation encoding pyrin Q148D R Booth, H J Lachmann, J D Gillmore, et al.
Complement (Basel, Switzerland)|January 1, 1988
Structure of C3f, a small peptide specifically released during inactivation of the third component of complementR A Harrison, T C Farries, F D Northrop, et al.
Rheumatology Advances in Practice|September 1, 2021
COVID-19 and autoinflammatory diseases: prevalence and outcomes of infection and early experience of vaccination in patients on biologicsClaire J Peet, Charalampia Papadopoulou, Bella Ruth M Sombrito, et al.
Pageof 43